Horn&Co. advised Immunorizon on the deal. Purple Biotech executed the acquisition of Immunorizon in consideration for up to $100 million. Purple Biotech Ltd. is a clinical-stage company...
This content is for Standard 1 Year members only. LoginJoin Now